Short answer · Medically reviewed summary · Last updated: 2026-04-07
Myotonic muscular dystrophy is most accurately referred to as Myotonic Dystrophy (DM), a multisystem disorder that encompasses two primary types: Type 1 (DM1) and Type 2 (DM2). While historically known by several names including Steinert’s disease or Curschmann-Batten-Steinert syndrome, the modern medical community standardizes the condition based on its genetic classification to ensure clarity for patients and providers. What are the common names and synonyms for Myotonic muscular dystrophy? Because Myotonic muscular dystrophy has been studied for over a century, it appears in medical literature under various titles.
Myotonic muscular dystrophy is most accurately referred to as Myotonic Dystrophy (DM), a multisystem disorder that encompasses two primary types: Type 1 (DM1) and Type 2 (DM2). While historically known by several names including Steinert’s disease or Curschmann-Batten-Steinert syndrome, the modern medical community standardizes the condition based on its genetic classification to ensure clarity for patients and providers.
Because Myotonic muscular dystrophy has been studied for over a century, it appears in medical literature under various titles. The primary umbrella term used today is "Myotonic Dystrophy." The condition is categorized into two distinct genetic forms: Myotonic muscular dystrophy type 1 (DM1) and Myotonic muscular dystrophy type 2 (DM2). Older literature, particularly from the early 20th century, may refer to the condition as "dystrophia myotonica" or "myotonia atrophica." Understanding these synonyms is crucial when reviewing historical medical records or searching legacy research databases.
The naming of Myotonic muscular dystrophy reflects the evolution of clinical neurology. Early researchers often named the disease after themselves or their colleagues, leading to historical synonyms such as Steinert’s disease (after Hans Steinert) or Curschmann-Batten-Steinert syndrome. As our understanding of the underlying genetics improved—specifically identifying that DM1 is caused by a CTG repeat expansion on the DMPK gene and DM2 by a CCTG expansion on the CNBP gene—the medical community shifted toward the current nomenclature. This shift prioritizes the genetic mechanism over the historical eponyms, allowing for more precise clinical classification and diagnostic consistency.
Standardized medical systems use specific identifiers to track Myotonic muscular dystrophy. These codes ensure that patients receive consistent care and allow researchers to aggregate global data. Key classifications include:
In modern clinical practice, the preferred terminology is simply Myotonic muscular dystrophy type 1 or type 2. Using these terms provides clarity regarding the inheritance pattern and the expected clinical course. While you may still see "Steinert’s disease" in older textbooks, current genetic counseling and neurology practice emphasize the "DM" abbreviation followed by the type number. This standard ensures that patients, caregivers, and the 26 members of the DiseaseMaps community can communicate effectively with their multidisciplinary medical teams.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.